MET and hepatocellular carcinoma: Mutations in APC, CSF1R, EGFR, ERBB4, FGFR3, FLT3, HRAS, KDR, MET, NPM1, PDGFRA, PIK3CA, RET, SMAD4 and STK11 were detected in HCC patients across all etiologies.